Search

everythinglearnresearchcommunity

for

Search:↓

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Cord blood platelets may have promising future medical uses but need more research.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Human skin can provide stem cells for tissue repair and regeneration, but there are challenges in obtaining and growing these cells safely.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Baicalin may help treat hair loss by promoting hair follicle growth and activating specific cellular pathways.

Platelet Rich Plasma-Derived Extracellular Vesicles show promise for healing and regeneration but need standardized methods for consistent results.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Mesenchymal stem cells could help treat radiation-induced bladder damage but more research is needed to overcome current limitations.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Cell aging can be both good and bad for tissue repair.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

Rabbits lacking the Hoxc13 gene show similar hair and skin issues to humans with ECTD-9, making them good for research on this condition.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.